E. Dalmau
Corporació Sanitària Parc Taulí(ES)Hospital de Sabadell(ES)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Advanced Breast Cancer Therapies, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Effect of different carbon sources on lipase production by Candida rugosa(2000)216 cited
- → Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Phase III Trial(2012)212 cited
- → Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: A new era begins(2013)133 cited
- → SEOM clinical guidelines in early stage breast cancer (2018)(2018)63 cited
- → Gastrointestinal stromal tumors(2006)45 cited
- → Current status of hormone therapy in patients with hormone receptor positive (HR+) advanced breast cancer(2014)44 cited
- → Analysis of the Pathologic Response to Primary Chemotherapy in Patients with Locally Advanced Breast Cancer Grouped According to Estrogen Receptor, Progesterone Receptor, and HER2 Status(2007)38 cited
- → Real-world effectiveness of dual HER2 blockade with pertuzumab and trastuzumab for neoadjuvant treatment of HER2-positive early breast cancer (The NEOPETRA Study)(2020)31 cited
- → Lipase production in continuous culture of Candida rugosa(2003)24 cited
- → Study of the drop size frequencies in a microbial growth system with an aqueous-organic culture medium: lipase production from Candida rugosa(1998)20 cited